UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects

Clinical pharmacology in drug development, 2013-10, Vol.2 (4), p.310-315

2013

Volltextzugriff (PDF)

Antihypertensive Response to Ketanserin: Influence of Race and Weight

Journal of clinical pharmacology, 1988-11, Vol.28 (11), p.1017-1022

1988

Volltextzugriff (PDF)

Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects

European journal of clinical pharmacology, 2011-05, Vol.67 (5), p.483-492

2011

Volltextzugriff (PDF)

Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep

American journal of physiology. Regulatory, integrative and comparative physiology, 1996-08, Vol.271 (2), p.373-R380

1996

Volltextzugriff (PDF)

Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure

American journal of physiology. Heart and circulatory physiology, 1997-11, Vol.273 (5), p.H2372-H2379

1997

Volltextzugriff (PDF)

Clearance receptors and endopeptidase : equal role in natriuretic peptide metabolism in heart failure

American journal of physiology. Heart and circulatory physiology, 1997-11, Vol.42 (5), p.H2372-H2379

1997

Volltextzugriff (PDF)

Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure

American journal of physiology. Heart and circulatory physiology, 1997-11, Vol.273 (5), p.H2372

1997

Volltextzugriff (PDF)

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

International journal of chronic obstructive pulmonary disease, 2013-01, Vol.8 (default), p.107-116

2013

Volltextzugriff (PDF)

Disposition of 14C-eptifibatide after intravenous administration to healthy men

Clinical therapeutics, 1998-03, Vol.20 (2), p.307-323

1998

Volltextzugriff (PDF)

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects

Drug metabolism and disposition, 2002-04, Vol.30 (4), p.430

2002

Volltextzugriff (PDF)

Drug interactions involving renal transport mechanisms: an overview

DICP (Cincinnati, Ohio), 1989-02, Vol.23 (2), p.116

1989

Volltextzugriff (PDF)

The Effect of Antacid and Cimetidine on the Oral Absorption of the Antifungal Agent SCH 39304

Journal of clinical pharmacology, 1990-07, Vol.30 (7), p.638-642

1990

Volltextzugriff (PDF)

Effect of Food, Antacid, and Age on the Pharmacokinetics of the Oral Thrombin Receptor Antagonist Vorapaxar (SCH 530348) in Healthy Volunteers

Clinical pharmacology in drug development, 2013-07, Vol.2 (3), p.223-230

2013

Volltextzugriff (PDF)

Effect of Food on the Oral Bioavailability of Isosorbide-5-Mononitrate Administered as an Extended-Release Tablet

Journal of clinical pharmacology, 1995-02, Vol.35 (2), p.151-158

1995

Volltextzugriff (PDF)

The Effect of Multiple Doses of Ketoconazole or Rifampin on the Single- and Multiple-Dose Pharmacokinetics of Vorapaxar

Journal of clinical pharmacology, 2013-05, Vol.53 (5), p.540-549

2013

Volltextzugriff (PDF)

Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trial

Clinical pharmacology in drug development, 2014-01, Vol.3 (1), p.18-24

2014

Volltextzugriff (PDF)

Effects of Ezetimibe on Cyclosporine Pharmacokinetics in Healthy Subjects

Journal of clinical pharmacology, 2006-03, Vol.46 (3), p.321-327

2006

Volltextzugriff (PDF)

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

Clinical pharmacology and therapeutics, 1991-08, Vol.50 (1), p.181-191

1991

Volltextzugriff (PDF)

Endopeptidase 24.11 Inhibition by SCH 42495 in Essential Hypertension

Hypertension (Dallas, Tex. 1979), 1993-07, Vol.22 (1), p.119-126

1993

Volltextzugriff (PDF)

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device

Clinical pharmacology in drug development, 2014-05, Vol.3 (3), p.222-228

2014

Volltextzugriff (PDF)

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

Clinical pharmacology in drug development, 2014-05, Vol.3 (3), p.229-234

2014

Volltextzugriff (PDF)

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions

Clinical pharmacokinetics, 2005-01, Vol.44 (5), p.467-494

2005

Volltextzugriff (PDF)

HPA Axis Effects of Mometasone Furoate/Formoterol (MF/F) Versus Fluticasone Propionate/Salmeterol (FP/S) Administered via Metered-Dose Inhaler (MDI

Chest, 2012-10, Vol.142 (4), p.685A-685B

2012

Volltextzugriff (PDF)

Hypothalamic-Pituitary-Adrenal Axis Effects of Mometasone Furoate/Formoterol Fumarate vs Fluticasone Propionate/Salmeterol Administered Through Metered-Dose Inhaler

Chest, 2013-12, Vol.144 (6), p.1795-1802

2013

Volltextzugriff (PDF)

Influence of Food on the Oral Bioavailability of Loratadine and Pseudoephedrine from Extended-Release Tablets in Healthy Volunteers

Journal of clinical pharmacology, 1996-10, Vol.36 (10), p.923-930

1996

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

KollektionOxford journals

Zeitschrift / SerieCurrent Medical Research And Opinion

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects

Antihypertensive Response to Ketanserin: Influence of Race and Weight

Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects

Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep

Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure

Clearance receptors and endopeptidase : equal role in natriuretic peptide metabolism in heart failure

Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

Disposition of 14C-eptifibatide after intravenous administration to healthy men

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects

Drug interactions involving renal transport mechanisms: an overview

The Effect of Antacid and Cimetidine on the Oral Absorption of the Antifungal Agent SCH 39304

Effect of Food, Antacid, and Age on the Pharmacokinetics of the Oral Thrombin Receptor Antagonist Vorapaxar (SCH 530348) in Healthy Volunteers

Effect of Food on the Oral Bioavailability of Isosorbide-5-Mononitrate Administered as an Extended-Release Tablet

The Effect of Multiple Doses of Ketoconazole or Rifampin on the Single- and Multiple-Dose Pharmacokinetics of Vorapaxar

Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trial

Effects of Ezetimibe on Cyclosporine Pharmacokinetics in Healthy Subjects

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

Endopeptidase 24.11 Inhibition by SCH 42495 in Essential Hypertension

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions

HPA Axis Effects of Mometasone Furoate/Formoterol (MF/F) Versus Fluticasone Propionate/Salmeterol (FP/S) Administered via Metered-Dose Inhaler (MDI

Hypothalamic-Pituitary-Adrenal Axis Effects of Mometasone Furoate/Formoterol Fumarate vs Fluticasone Propionate/Salmeterol Administered Through Metered-Dose Inhaler

Influence of Food on the Oral Bioavailability of Loratadine and Pseudoephedrine from Extended-Release Tablets in Healthy Volunteers

Aktive Filter

Suchergebnisse filtern